Apogee Therapeutics (APGE) EPS (Basic) (2022 - 2026)
Apogee Therapeutics (APGE) posted quarterly EPS (Basic) of -$1.06 for Q1 2026, down 11.87% year-over-year from -$1.21 in Q1 2025, and up 6.96% quarter-over-quarter from -$1.14 in Q4 2025.
Apogee Therapeutics (APGE) EPS (Basic) (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported EPS (Basic) for 5 consecutive years, with -$1.06 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 11.87% year-over-year to -$1.06; the TTM figure through Mar 2026 stood at -$3.94 (down 11.68% YoY), while the FY2025 annual figure was -$4.22, down 27.74% from the prior year.
- EPS (Basic) grew to -$1.06 in Q1 2026 per APGE's latest filing, from -$1.14 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.51 in Q3 2023 and bottomed at -$9.46 in Q3 2022.
- Historically, EPS (Basic) has averaged -$2.09 across 5 years, with a median of -$1.14 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 94.65% in 2023 and fell as far as 159.98% in 2023.
- Apogee Therapeutics' EPS (Basic) stood at -$5.69 in 2022, then surged by 77.69% to -$1.27 in 2023, then climbed by 4.04% to -$1.22 in 2024, then grew by 6.12% to -$1.14 in 2025, then gained by 6.96% to -$1.06 in 2026.
- Business Quant data shows APGE's EPS (Basic) at -$1.06 in Q1 2026, -$1.14 in Q4 2025, and -$1.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | -1.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.14 |
| Mar 31, 2026 | -1.06 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -1.11 |
| Jun 30, 2025 | -1.13 |
| Mar 31, 2025 | -0.95 |
| Dec 31, 2024 | -1.22 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -1.27 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -3.78 |
| Mar 31, 2023 | -2.51 |
| Dec 31, 2022 | -5.69 |
| Sep 30, 2022 | -9.46 |
| Jun 30, 2022 | -1.45 |